- Home
- Publications
- Publication Search
- Publication Details
Title
Block-And-Lock Strategies to Cure HIV Infection
Authors
Keywords
-
Journal
Viruses-Basel
Volume 12, Issue 1, Pages 84
Publisher
MDPI AG
Online
2020-01-13
DOI
10.3390/v12010084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DIABLO/SMAC mimetics selectively kill HIV-1-infected resting memory CD4+ T cells: a potential role in a cure strategy for HIV-1 infection
- (2019) Grant R. Campbell et al. Autophagy
- Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies
- (2019) Aurélie Delannoy et al. Viruses-Basel
- HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
- (2019) Ravindra K. Gupta et al. NATURE
- Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment
- (2019) Sona Talaei et al. Chemical Biology & Drug Design
- Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
- (2019) Gerlinde Vansant et al. Retrovirology
- Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
- (2019) Chuan Li et al. Epigenetics & Chromatin
- Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV
- (2019) Qingli Niu et al. JOURNAL OF CLINICAL INVESTIGATION
- Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription
- (2019) Guillaume Mousseau et al. mBio
- Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists
- (2019) Amanda B. Macedo et al. Frontiers in Immunology
- Novel Latency Reversal Agents for HIV-1 Cure
- (2018) Adam M. Spivak et al. Annual Review of Medicine
- Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
- (2018) Youry Kim et al. Cell Host & Microbe
- Rapid rebound of a preexisting CXCR4-tropic HIV variant after allogeneic transplantation with CCR5 delta32 homozygous stem cells
- (2018) J Verheyen et al. CLINICAL INFECTIOUS DISEASES
- Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression
- (2018) Thomas D. Zaikos et al. JOURNAL OF VIROLOGY
- Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs
- (2018) Amy E. Baxter et al. Retrovirology
- HIV latency in isolated patient CD4 + T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing
- (2018) Steven A. Yukl et al. Science Translational Medicine
- Therapeutic vaccination for HIV
- (2018) Kathryn E. Stephenson Current Opinion in HIV and AIDS
- Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration
- (2018) Vasudevan Achuthan et al. Cell Host & Microbe
- Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro
- (2018) Shin-ichiro Hattori et al. Frontiers in Microbiology
- Inhibitors of Signaling Pathways that Block Reversal of HIV-1 Latency
- (2018) Benni Vargas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SMAC Mimetics Induce Autophagy-Dependent Apoptosis of HIV-1-Infected Resting Memory CD4+ T Cells
- (2018) Grant R. Campbell et al. Cell Host & Microbe
- RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency
- (2018) Catalina Méndez et al. Retrovirology
- Insight in HIV Integration Site Selection Provides a Block-and-Lock Strategy for a Functional Cure of HIV Infection
- (2018) Zeger Debyser et al. Viruses-Basel
- Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency
- (2018) Sushama Telwatte et al. PLoS Pathogens
- Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition
- (2017) Nathan W. Cummins et al. JOURNAL OF VIROLOGY
- The emerging safety profile of JAK inhibitors in rheumatic disease
- (2017) Kevin L. Winthrop Nature Reviews Rheumatology
- HIV Latency: Should We Shock or Lock?
- (2017) Gilles Darcis et al. TRENDS IN IMMUNOLOGY
- HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells
- (2017) Daniela Cesana et al. Nature Communications
- In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a “Block-and-Lock” Strategy for HIV-1 Treatment
- (2017) Cari F. Kessing et al. Cell Reports
- Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors
- (2017) Christina Gavegnano et al. PLoS Pathogens
- Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation
- (2017) Maxime J. Jean et al. Frontiers in Microbiology
- The Molecular Basis for Human Immunodeficiency Virus Latency
- (2017) Uri Mbonye et al. Annual Review of Virology
- HIV Latency TORn Down
- (2016) Mauro Giacca Cell Host & Microbe
- The mTOR Complex Controls HIV Latency
- (2016) Emilie Besnard et al. Cell Host & Microbe
- Non-human primates in HIV research: Achievements, limits and alternatives
- (2016) Thalía Garcia-Tellez et al. INFECTION GENETICS AND EVOLUTION
- The Cleavage and Polyadenylation Specificity Factor 6 (CPSF6) Subunit of the Capsid-recruited Pre-messenger RNA Cleavage Factor I (CFIm) Complex Mediates HIV-1 Integration into Genes
- (2016) Sheeba Rasheedi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Heat Shock Protein 90 Prevents HIV Rebound
- (2016) Pheroze Joshi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy.
- (2016) Nai-Jung Chiang et al. JOURNAL OF CLINICAL ONCOLOGY
- Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size
- (2016) Nathan W. Cummins et al. JOURNAL OF VIROLOGY
- CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape
- (2016) Gang Wang et al. MOLECULAR THERAPY
- Nuclear landscape of HIV-1 infection and integration
- (2016) Marina Lusic et al. NATURE REVIEWS MICROBIOLOGY
- Position effects influence HIV latency reversal
- (2016) Heng-Chang Chen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy
- (2016) Hiromi Imamichi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV-1 Reservoirs During Suppressive Therapy
- (2016) Kirston Barton et al. TRENDS IN MICROBIOLOGY
- Preclinical shock strategies to reactivate latent HIV-1
- (2016) Gilles Darcis et al. Current Opinion in HIV and AIDS
- Position effects influence HIV latency reversal
- (2016) Heng-Chang Chen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Development of 5‘ LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals
- (2016) Kateřina Trejbalová et al. Clinical Epigenetics
- Broadly Neutralizing Antibodies for HIV Eradication
- (2016) Kathryn E. Stephenson et al. Current HIV/AIDS Reports
- LEDGIN-mediated Inhibition of Integrase–LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV
- (2016) Lenard S. Vranckx et al. EBioMedicine
- Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner
- (2016) Hong Kim et al. Scientific Reports
- HIV-1 Integration Landscape during Latent and Active Infection
- (2015) Lillian B. Cohn et al. CELL
- Didehydro-Cortistatin A Inhibits HIV-1 Tat Mediated Neuroinflammation and Prevents Potentiation of Cocaine Reward in Tat Transgenic Mice
- (2015) Sonia Mediouni et al. CURRENT HIV RESEARCH
- Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1
- (2015) S. Bouchat et al. EMBO Molecular Medicine
- Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma
- (2015) Y. Oki et al. HAEMATOLOGICA
- Nuclear architecture dictates HIV-1 integration site selection
- (2015) Bruna Marini et al. NATURE
- Host factors for retroviral integration site selection
- (2015) Zeger Debyser et al. TRENDS IN BIOCHEMICAL SCIENCES
- The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
- (2015) Guillaume Mousseau et al. mBio
- Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
- (2015) Hsin-Kai Liao et al. Nature Communications
- Direct Visualization of HIV-1 Replication Intermediates Shows that Capsid and CPSF6 Modulate HIV-1 Intra-nuclear Invasion and Integration
- (2015) Christopher R. Chin et al. Cell Reports
- The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
- (2015) Ole S. Søgaard et al. PLoS Pathogens
- Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma
- (2015) Y. Oki et al. HAEMATOLOGICA
- Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing
- (2015) Chantelle Ahlenstiel et al. Molecular Therapy-Nucleic Acids
- Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation
- (2014) Timothy J. Henrich et al. ANNALS OF INTERNAL MEDICINE
- Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
- (2014) Craig Fenwick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus ReactivationIn Vitro
- (2014) Christina Gavegnano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32 Mutation
- (2014) Lambros Kordelas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heat shock protein 90 controls HIV-1 reactivation from latency
- (2014) I. Anderson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat protein
- (2014) Zhitao Wan et al. Retrovirology
- Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
- (2014) T. A. Wagner et al. SCIENCE
- Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
- (2014) F. Maldarelli et al. SCIENCE
- Immunologic strategies for HIV-1 remission and eradication
- (2014) D. H. Barouch et al. SCIENCE
- Presence ofC11orf95-MKL2fusion is a consistent finding in chondroid lipomas: a study of eight cases
- (2013) Uta Flucke et al. HISTOPATHOLOGY
- HIV-associated chronic immune activation
- (2013) Mirko Paiardini et al. IMMUNOLOGICAL REVIEWS
- Non-Catalytic Site HIV-1 Integrase Inhibitors Disrupt Core Maturation and Induce a Reverse Transcription Block in Target Cells
- (2013) Mini Balakrishnan et al. PLoS One
- Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation
- (2013) K. A. Jurado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrated platform for genome-wide screening and construction of high-density genetic interaction maps in mammalian cells
- (2013) M. Kampmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions
- (2013) Belete Desimmie et al. Retrovirology
- Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage
- (2013) Erwann Le Rouzic et al. Retrovirology
- Lost in Transcription: Molecular Mechanisms that Control HIV Latency
- (2013) Ran Taube et al. Viruses-Basel
- Small-Molecule Inhibitors of the LEDGF/p75 Binding Site of Integrase Block HIV Replication and Modulate Integrase Multimerization
- (2012) Frauke Christ et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV Transcription
- (2012) Guillaume Mousseau et al. Cell Host & Microbe
- Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
- (2012) Liang Shan et al. IMMUNITY
- New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action
- (2012) Manuel Tsiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors
- (2012) Jacques J. Kessl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells
- (2012) Rik Schrijvers et al. Retrovirology
- Hyperthermia Stimulates HIV-1 Replication
- (2012) Ferdinand Roesch et al. PLoS Pathogens
- Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers
- (2011) Komal Jhaveri et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Allosteric Inhibitor Development Targeting HIV-1 Integrase
- (2011) Laith Q. Al-Mawsawi et al. ChemMedChem
- Identification of IGHCδ-BACH2 fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell lymphoma/leukemia
- (2011) Satoru Kobayashi et al. GENES CHROMOSOMES & CANCER
- Triptolide and its expanding multiple pharmacological functions
- (2011) Qiuyan Liu INTERNATIONAL IMMUNOPHARMACOLOGY
- Impaired Infectivity of Ritonavir-resistant HIV Is Rescued by Heat Shock Protein 90AB1
- (2011) Pheroze Joshi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Unknown
- (2011) Shay Matalon et al. MOLECULAR MEDICINE
- Curaxins: Anticancer Compounds That Simultaneously Suppress NF- B and Activate p53 by Targeting FACT
- (2011) A. V. Gasparian et al. Science Translational Medicine
- Chromatin Dynamics
- (2010) Michael R. Hübner et al. Annual Review of Biophysics
- Triptolide induces adverse effect on reproductive parameters of female Sprague-Dawley rats
- (2010) Jing Liu et al. DRUG AND CHEMICAL TOXICOLOGY
- Gyrase B Inhibitor Impairs HIV-1 Replication by Targeting Hsp90 and the Capsid Protein
- (2010) Luciano Vozzolo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Establishment of HIV Latency in Primary CD4+ Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb Restriction
- (2010) M. Tyagi et al. JOURNAL OF VIROLOGY
- Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication
- (2010) Frauke Christ et al. Nature Chemical Biology
- Targeting the PI3K/Akt Cell Survival Pathway to Induce Cell Death of HIV-1 Infected Macrophages with Alkylphospholipid Compounds
- (2010) Amanda Lucas et al. PLoS One
- The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro
- (2010) Brian B. Hasinoff et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Transcription through the HIV-1 nucleosomes: Effects of the PBAF complex in Tat activated transcription
- (2010) Rebecca Easley et al. VIROLOGY
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- CpG Methylation Controls Reactivation of HIV from Latency
- (2009) Jana Blazkova et al. PLoS Pathogens
- Effects of Retroviruses on Host Genome Function
- (2008) Patric Jern et al. Annual Review of Genetics
- Closed Chromatin Architecture Is Induced by an RNA Duplex Targeting the HIV-1 Promoter Region
- (2008) Kazuo Suzuki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic Silencing of Human Immunodeficiency Virus (HIV) Transcription by Formation of Restrictive Chromatin Structures at the Viral Long Terminal Repeat Drives the Progressive Entry of HIV into Latency
- (2008) R. Pearson et al. JOURNAL OF VIROLOGY
- Proteomic Studies Reveal Coordinated Changes in T-Cell Expression Patterns upon Infection with Human Immunodeficiency Virus Type 1
- (2008) J. H. Ringrose et al. JOURNAL OF VIROLOGY
- Human macrophages support persistent transcription from unintegrated HIV-1 DNA
- (2007) Jeremy Kelly et al. VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More